SG Americas Securities’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-32,408
| Closed | -$1.9M | – | 3592 |
|
|
2023
Q4 | $1.9M | Sell |
32,408
-17,170
| -35% | -$965K | 0.02% | 701 |
|
|
2023
Q3 | $2.16M | Buy |
49,578
+25,335
| +105% | +$905K | 0.02% | 672 |
|
|
2023
Q2 | $876K | Buy |
24,243
+19,898
| +458% | +$820K | 0.01% | 1119 |
|
|
2023
Q1 | $162K | Buy |
+4,345
| New | +$195K | ﹤0.01% | 2579 |
|
|
2022
Q4 | – | Sell |
-45,289
| Closed | -$3.16M | – | 3468 |
|
|
2022
Q3 | $3.16M | Buy |
45,289
+34,637
| +325% | +$2.56M | 0.04% | 382 |
|
|
2022
Q2 | $715K | Sell |
10,652
-46,658
| -81% | -$2.97M | 0.01% | 1631 |
|
|
2022
Q1 | $4.71M | Buy |
57,310
+46,511
| +431% | +$4.76M | 0.03% | 440 |
|
|
2021
Q4 | $1.58M | Buy |
10,799
+5,344
| +98% | +$830K | 0.01% | 1293 |
|
|
2021
Q3 | $965K | Sell |
5,455
-3,307
| -38% | -$532K | ﹤0.01% | 1942 |
|
|
2021
Q2 | $1.42M | Sell |
8,762
-5,317
| -38% | -$854K | 0.01% | 1331 |
|
|
2021
Q1 | $2.41M | Buy |
14,079
+12,300
| +691% | +$2.44M | 0.01% | 927 |
|
|
2020
Q4 | $391K | Sell |
1,779
-6,318
| -78% | -$1.37M | ﹤0.01% | 2173 |
|
|
2020
Q3 | $1.34M | Sell |
8,097
-15,610
| -66% | -$2.14M | 0.01% | 1015 |
|
|
2020
Q2 | $2.71M | Buy |
23,707
+15,445
| +187% | +$1.5M | 0.02% | 648 |
|
|
2020
Q1 | $635K | Buy |
8,262
+4,586
| +125% | +$411K | 0.01% | 1645 |
|
|
2019
Q4 | $474K | Buy |
+3,676
| New | +$355K | ﹤0.01% | 1841 |
|
|
2019
Q3 | – | Sell |
-25,907
| Closed | -$2.67M | – | 3281 |
|
|
2019
Q2 | $2.67M | Buy |
25,907
+21,687
| +514% | +$1.69M | 0.02% | 843 |
|
|
2019
Q1 | $309K | Sell |
4,220
-17,482
| -81% | -$1.19M | ﹤0.01% | 2239 |
|
|
2018
Q4 | $921K | Buy |
+21,702
| New | +$865K | 0.01% | 1400 |
|
|
2018
Q1 | – | Sell |
-45,430
| Closed | -$829K | – | 3623 |
|
|
2017
Q4 | $829K | Buy |
+45,430
| New | +$705K | 0.01% | 1510 |
|
|
2016
Q3 | – | Sell |
-18,049
| Closed | -$99K | – | 3537 |
|
|
2016
Q2 | $99K | Buy |
+18,049
| New | +$288K | ﹤0.01% | 2394 |
|
|
2014
Q3 | – | Sell |
-9,116
| Closed | -$182K | – | 2888 |
|
|
2014
Q2 | $182K | Buy |
+9,116
| New | +$176K | ﹤0.01% | 2075 |
|
Other funds holding MRTX
SG Americas Securities's MRTX Position: Q1 2024 in Review
SG Americas Securities sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 32,408 shares — an estimated $1.9M sold.
SG Americas Securities first reported a position in MRTX in Q2 2014 and held it in 22 quarters. The position peaked at $4.71M in Q1 2022. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.
- SG Americas Securities reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
- SG Americas Securities sold 32,408 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $1.9M.
- SG Americas Securities first reported a position in Mirati Therapeutics, Inc. Common Stock in Q2 2014 and held it in 22 quarters.
- SG Americas Securities's Mirati Therapeutics, Inc. Common Stock position peaked at $4.71M in Q1 2022.
- 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.
Based on SG Americas Securities's 13F filing for Q1 2024, filed 6 May 2024.